Nexentis Unveils AI-Powered MITOLINE™ Website Showcasing MitoCareX Integration and RTB Solar Assets
Nexentis launched a new corporate website at www.nexentistech.com after rebranding from N2OFF, spotlighting its AI-driven MITOLINE™ discovery engine. The site outlines MitoCareX Bio’s mitochondrial SLC25 small-molecule programs for oncology and metabolic diseases and details non-core RTB solar investments across four European projects.
1. Website Launch and Rebranding
Nexentis launched its new corporate website at www.nexentistech.com, marking its rebrand from N2OFF in October 2025 and providing a central access point for investors, partners and researchers.
2. AI-Driven Discovery Platform
The site features detailed information on the proprietary MITOLINE™ engine, which uses advanced algorithms and structure-guided virtual screening to drive small-molecule program development targeting mitochondrial SLC25 carriers.
3. Solar RTB Investments
It also highlights non-core solar energy assets under the RTB business model, outlining four projects across three EU countries managed to optimize value while supporting core biotech operations.